Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 21-Nov-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Nifedipine Extended-Release Tablets USP, 30 mg, 60 mg and 90 mg.
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 21-Nov-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Nifedipine Extended-Release Tablets USP, 30 mg, 60 mg and 90 mg.